GlassScriptPhysician profile
John Warren Holshouser
NPI 1568474351
$6,621.64
in general payments reported to CMS, 2019-2025
14 companies · $676 in 2025
The $676 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,946 · 2020: $302 · 2021: $353 · 2022: $415 · 2023: $1,146 · 2024: $1,784 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,605.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,893.16 | 2019-2025 | Watchman Flx, Watchman Access System, General - Therapies |
| Atricure, INC. | $834.03 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Biosense Webster, INC. | $604.26 | 2021-2024 | Carto 3, Qdot Micro Catheter |
| Medtronic, INC. | $504.78 | 2021-2025 | Affera Mapping System, Na, Linq II |
| Biotronik INC. | $472.52 | 2019-2025 | Acticor 7 Vr-T Dx, Selectra, Amvia Edge |
| Abbott Laboratories | $423.91 | 2021-2024 | Aveir |
| Cvrx, INC. | $335.20 | 2023-2024 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $268.55 | 2019-2023 | Eliquis |
| Amgen INC. | $124.99 | 2020 | |
| Impulse Dynamics (USA) INC. | $55.86 | 2024-2025 | Optimizer |
| Janssen Pharmaceuticals, INC | $36.20 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.72 | 2024 | Lifevest |
| Kestra Medical Technology Services, INC. | $25.88 | 2024 | Assure Wcd |
| Pfizer INC. | $14.58 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Holshouser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.